Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor physiology and cell kinetics

M W Dewhirst1, S M LaRue, L Gerweck

  • 1Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.

Seminars in Veterinary Medicine and Surgery (Small Animal)
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells.

Oncogene·2021
Same author

A retrospective analysis of stereotactic body radiation therapy for canine heart base tumors: 26 cases.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2020
Same author

Outcome of 9 dogs treated with stereotactic radiation therapy for primary or metastatic vertebral osteosarcoma.

Veterinary and comparative oncology·2017
Same author

Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.

Cancer chemotherapy and pharmacology·2017
Same author

Nitroprusside improves tumor perfusion during local 42°C hyperthermia.

Veterinary anaesthesia and analgesia·2017
Same author

Predicting clinical outcome in feline oral squamous cell carcinoma: tumour initiating cells, telomeres and telomerase.

Veterinary and comparative oncology·2014

Targeting unique tumor physiology, like acidity and hypoxia, offers new therapeutic strategies. Overcoming tumor barriers and using cell kinetics can improve treatment effectiveness and patient selection for cancer therapies.

Area of Science:

  • Oncology
  • Cancer Biology
  • Translational Medicine

Background:

  • Tumor physiological abnormalities are linked to treatment resistance and metastasis.
  • Solid tumors exhibit unique physiological states, offering potential for targeted therapies.
  • Current targeted therapies face challenges due to physiological barriers within tumors.

Purpose of the Study:

  • To explore therapeutic strategies targeting unique tumor cell physiology.
  • To investigate methods for overcoming physiological barriers in solid tumors.
  • To evaluate the utility of tumor cell kinetics in guiding treatment decisions.

Main Methods:

  • Investigating drugs targeting acidotic and hypoxic tumor cells.
  • Developing strategies to address high interstitial pressures and adhesion molecule defects.

Related Experiment Videos

  • Analyzing tumor cell kinetics for patient stratification and treatment selection.

    • Main Results:

    • Targeting tumor-specific acidosis and hypoxia may provide selective adjuvant therapy.
    • Overcoming interstitial pressures and adhesion defects is crucial for targeted therapy delivery.
    • Tumor cell kinetics parameters are valuable for predicting treatment response.

    Conclusions:

    • Targeting unique tumor physiology presents a promising avenue for cancer treatment.
    • Addressing tumor microenvironment barriers is essential for effective targeted therapies.
    • Tumor cell kinetics can personalize cancer treatment regimens and improve outcomes.